Serologic aspects of treating immune thrombocytopenic purpura using intravenous Rh immune globulin
By:
Paid access
|Oct 2020References
- Sandler SG. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin. Transfus Med Rev 2001;15:67-76.
- Rushin J, Rumsey DH, Ewing CA, et al. Detection of multiple passively acquired alloantibodies following infusions of intravenous Rh immune globulin. Transfusion 2000;40:551-4.
- McMillian R, Lopez-Dee J, Loftus JC. Autoantibodies to αIIbβ3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on αIib. Blood 2001;97:2171-2.
- Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 1975;292:230-6.
- Karpatkin S, Strick N, Karpatkin MB, et al. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 1972;52:776-85.
- Hou M, Stockelberg D, Kutti J. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies. Br J Haematol 1997;98:64-7.
- Williams Y, Lynch S, McCann S, et al. Correlation of platelet Fc gammaRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura. Br J Haematol 1998;101:779-82.
- Hurlimann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using the purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol 1997;98:328-35.
- Bussel JB. Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol 2000;37:261-6.
- Kaznelson P. Verschwinden den haemorrhagischen diathese bei einem fallen von essentieller thrombopenia (Frank) nach milz extripation. Splenogene thrombolitsche purpura. Wien Klin Wochenschr 1916;29:1451-4.
- Wintrobe MM. ACTH and cortisone in hemopoietic disorders. Am J Med 1950;9:715-7.
- Imbach P, Barandum S, D’Appuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in children. Lancet 1981;1:1228-30.
- Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia: competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet 1983;2:193-5.
- Salama A, Kiefel V, Amberg R, et al. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho[D]). Blut 1984;49:29-35.
- Salama A, Kiefel V, Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986;22:241-51.
- Becker T, Kuenzlen E, Salama A, et al. Treatment of childhood idiopathic thrombocytopenic purpura with rhesus antibodies (anti-D). Eur J Pediatr 1986; 145:166-99.
- Oksenhendler E, Bierling P, Bossard Y, et al. Anti-Rh immunoglobulin therapy for human immunodeficiency virus related immune thrombocytopenic purpura. Blood 1988;71:1499-502.
- Bussel JB, Graziano JN, Kimberly RP, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity and mechanism of effect. Blood 1991;77:1884-94.
- Gringeri A, Cattaneo M, Santagostino E, et al. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 1992;80:337-40.
- Andrew M, Blanchette VS, Adams M, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992;120:552-7.
- Caglayan S, Aksit S, Yaprak I, et al. Steroid-free interval with anti-D in chronic idiopathic thrombocytopenic purpura. Acta Paediatr Jpn 1993;35:36-8.
- Borgna-Pignatti C, Battisti L, Zecca M, et al. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol 1994;88:618-20.
- Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-7.
- Godeau B, Oksenhendler E, Bartholeyns J, et al. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D. Transfusion 1996;36:328-30.
- Scaradavou A, Woo B, Woloski BMR, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-700.
- Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/ kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001;112:1076-8.
- Bussel JB, Kaufmann CP, Ware RE, Woloski BM. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol 2001; 67:27-33.
- Shulman NR, Weinrach RS, Libre EP, Andrews HL. The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians 1965;78:374-90.
- Rho(D) Immune Globulin Intravenous (Human)/ WinRho SDF™ package insert. January 20, 2000. Winnepeg, Canada: Cangene Corporation. Distributed by NABI, Boca Raton, FL.
- Kennedy MS, McNanie J, Waheed A. Detection of anti-D following antepartum injections of Rh immune globulin. Immunohematology 1998;14:138-40.
- Roberti I, Bagtas JF, Reisman L, Murphy S. Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura. Clin Pediatr 2001;40:61-2.
DOI: https://doi.org/10.21307/immunohematology-2019-562 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 106 - 110
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 C.M. Savasman, S.G. Sandler, published by American National Red Cross
This work is licensed under the Creative Commons License.